Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
357 | 31315 | 28.2 | 57% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
19 | 708907 | CHEMISTRY, ANALYTICAL//ENVIRONMENTAL SCIENCES//ATMOSPHERIC ENVIRONMENT |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
492 | 14766 | CONTRACEPTION//EMERGENCY CONTRACEPTION//MEDICAL ABORTION |
2041 | 4887 | MARE//ANABOLIC ANDROGENIC STEROIDS//TAYLORELLA EQUIGENITALIS |
2272 | 4206 | BIOANALYSIS//LC NMR//DRIED BLOOD SPOT DBS |
2318 | 4052 | DOPING CONTROL//EPITESTOSTERONE//DOPING ANALYSIS |
2938 | 2226 | CLENBUTEROL//RACTOPAMINE//ZILPATEROL HYDROCHLORIDE |
3393 | 1178 | VISNAGIN//AMMI VISNAGA//FURANOCHROMONES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CONTRACEPTION | Journal | 2517 | 60% | 9% | 2765 |
2 | EMERGENCY CONTRACEPTION | Author keyword | 808 | 85% | 1% | 429 |
3 | MEDICAL ABORTION | Author keyword | 569 | 86% | 1% | 291 |
4 | LEVONORGESTREL | Author keyword | 417 | 67% | 1% | 380 |
5 | CLENBUTEROL | Author keyword | 392 | 66% | 1% | 360 |
6 | MISOPROSTOL | Author keyword | 385 | 46% | 2% | 629 |
7 | ANABOLIC STEROIDS | Author keyword | 349 | 63% | 1% | 346 |
8 | INTRAUTERINE DEVICE | Author keyword | 330 | 66% | 1% | 306 |
9 | ANABOLIC ANDROGENIC STEROIDS | Author keyword | 290 | 76% | 1% | 201 |
10 | MARE | Author keyword | 279 | 50% | 1% | 402 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EMERGENCY CONTRACEPTION | 808 | 85% | 1% | 429 | Search EMERGENCY+CONTRACEPTION | Search EMERGENCY+CONTRACEPTION |
2 | MEDICAL ABORTION | 569 | 86% | 1% | 291 | Search MEDICAL+ABORTION | Search MEDICAL+ABORTION |
3 | CONTRACEPTION | 523 | 38% | 3% | 1087 | Search CONTRACEPTION | Search CONTRACEPTION |
4 | LEVONORGESTREL | 417 | 67% | 1% | 380 | Search LEVONORGESTREL | Search LEVONORGESTREL |
5 | CLENBUTEROL | 392 | 66% | 1% | 360 | Search CLENBUTEROL | Search CLENBUTEROL |
6 | MISOPROSTOL | 385 | 46% | 2% | 629 | Search MISOPROSTOL | Search MISOPROSTOL |
7 | ANABOLIC STEROIDS | 349 | 63% | 1% | 346 | Search ANABOLIC+STEROIDS | Search ANABOLIC+STEROIDS |
8 | INTRAUTERINE DEVICE | 330 | 66% | 1% | 306 | Search INTRAUTERINE+DEVICE | Search INTRAUTERINE+DEVICE |
9 | ANABOLIC ANDROGENIC STEROIDS | 290 | 76% | 1% | 201 | Search ANABOLIC+ANDROGENIC+STEROIDS | Search ANABOLIC+ANDROGENIC+STEROIDS |
10 | MARE | 279 | 50% | 1% | 402 | Search MARE | Search MARE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEVONORGESTREL | 562 | 65% | 2% | 530 |
2 | YUZPE REGIMEN | 481 | 86% | 1% | 247 |
3 | ANABOLIC STEROIDS | 477 | 60% | 2% | 519 |
4 | UNINTENDED PREGNANCY | 464 | 60% | 2% | 509 |
5 | VAGINAL MISOPROSTOL | 461 | 74% | 1% | 342 |
6 | CLENBUTEROL | 410 | 63% | 1% | 415 |
7 | BOVINE URINE | 310 | 84% | 1% | 167 |
8 | MIFEPRISTONE | 301 | 52% | 1% | 407 |
9 | ETHINYL ESTRADIOL | 289 | 48% | 1% | 440 |
10 | ANDROGENIC STEROIDS | 279 | 84% | 0% | 154 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONTRACEPTION | 2517 | 60% | 9% | 2765 |
2 | EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE | 246 | 50% | 1% | 351 |
3 | FAMILY PLANNING PERSPECTIVES | 220 | 37% | 2% | 472 |
4 | CONTRACEPTIVE DELIVERY SYSTEMS | 162 | 78% | 0% | 108 |
5 | JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE | 125 | 42% | 1% | 227 |
6 | BIOANALYSIS | 123 | 30% | 1% | 340 |
7 | BRITISH JOURNAL OF FAMILY PLANNING | 78 | 49% | 0% | 118 |
8 | PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH | 69 | 40% | 0% | 136 |
9 | ADVANCES IN CONTRACEPTION | 52 | 46% | 0% | 85 |
10 | REPRODUCTIVE HEALTH MATTERS | 44 | 26% | 0% | 146 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Contraceptive failure in the United States | 2011 | 191 | 51 | 69% |
Ion suppression in mass spectrometry | 2003 | 696 | 13 | 77% |
Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review | 2015 | 3 | 18 | 100% |
Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry | 2005 | 498 | 36 | 61% |
Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS | 2007 | 238 | 76 | 68% |
Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry | 2010 | 168 | 75 | 52% |
AN OVERVIEW OF MATRIX EFFECTS IN LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY | 2011 | 153 | 130 | 44% |
Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules | 2010 | 213 | 72 | 38% |
The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis | 2014 | 16 | 96 | 59% |
Key elements of bioanalytical method validation for small molecules | 2007 | 133 | 1 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIXBY GLOBAL REPROD HLTH | 120 | 63% | 0.4% | 122 |
2 | DOCO | 52 | 77% | 0.1% | 36 |
3 | BIXBY REPROD HLTH POLICY | 47 | 84% | 0.1% | 26 |
4 | REPROD HLTH POLICY | 40 | 58% | 0.1% | 46 |
5 | PREVENT DOPING | 35 | 35% | 0.3% | 80 |
6 | ANTIDOPING | 30 | 39% | 0.2% | 61 |
7 | FAMILY PLANNING CLIN | 30 | 69% | 0.1% | 25 |
8 | REPRO | 29 | 72% | 0.1% | 23 |
9 | DOPING CONTROL | 27 | 28% | 0.3% | 81 |
10 | OFF POPULAT | 24 | 19% | 0.4% | 115 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000002156 | MENOPAUSE//POLYCYSTIC OVARY SYNDROME//ESTROGEN |
2 | 0.0000001841 | SEXUALLY TRANSMITTED DISEASES//SEXUALLY TRANSMITTED INFECTIONS//AIDS AND BEHAVIOR |
3 | 0.0000001528 | STEROIDS//OSW 1//SQUALAMINE |
4 | 0.0000001489 | ECTOPIC PREGNANCY//HYDATIDIFORM MOLE//GESTATIONAL TROPHOBLASTIC NEOPLASIA |
5 | 0.0000001450 | REPRODUCTIVE BIOLOGY//FERTILITY AND STERILITY//HUMAN REPRODUCTION |
6 | 0.0000001396 | CYTOCHROME P450//GSTM1//GSTT1 |
7 | 0.0000001290 | FAMILY STUDIES//PSYCHOLOGY, DEVELOPMENTAL//SOCIAL WORK |
8 | 0.0000001258 | OBSTETRICS & GYNECOLOGY//PRE ECLAMPSIA//AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY |
9 | 0.0000001223 | JOURNAL OF CHROMATOGRAPHY A//CAPILLARY ELECTROPHORESIS//ELECTROPHORESIS |
10 | 0.0000001183 | MOLECULAR IMPRINTING//MOLECULARLY IMPRINTED POLYMER//MOLECULARLY IMPRINTED POLYMERS |